PIERIS PHARMACEUTICALS INC - COM (PIRS)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
26,647,807
Share change
-5,527,075
Total reported value
$102,050,163
Put/Call ratio
98%
Price per share
$3.83
Number of holders
73
Value change
-$15,806,173
Number of buys
33
Number of sells
58

Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q2 2021

As of 30 Jun 2021, PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,647,807 shares. The largest 10 holders included BVF INC/IL, Aquilo Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MORGAN STANLEY, BlackRock Inc., PLATINUM INVESTMENT MANAGEMENT LTD, VANGUARD GROUP INC, Candriam Luxembourg S.C.A., and Point72 Asset Management, L.P.. This page lists 73 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.